Fiche publication
Date publication
novembre 2010
Journal
The Lancet. Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CLAVEL Christine
Tous les auteurs :
de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX,
Lien Pubmed
Résumé
Knowledge about the distribution of human papillomavirus (HPV) genotypes in invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical cancer.
Mots clés
Adenocarcinoma, epidemiology, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Carcinoma, Adenosquamous, epidemiology, Carcinoma, Squamous Cell, epidemiology, Cross-Sectional Studies, DNA, Viral, isolation & purification, Female, Genetic Testing, Genotype, Humans, International Cooperation, Linear Models, Logistic Models, Mass Screening, methods, Middle Aged, Neoplasm Invasiveness, Papillomaviridae, genetics, Papillomavirus Infections, epidemiology, Papillomavirus Vaccines, therapeutic use, Paraffin Embedding, Polymerase Chain Reaction, Retrospective Studies, Uterine Cervical Neoplasms, epidemiology, Young Adult
Référence
Lancet Oncol.. 2010 Nov;11(11):1048-56
